Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial.
Ulf K TeichgräberThomas LehmannMaja IngwersenRené AschenbachThomas ZellerKlaus BrechtelErwin BlessingMichael LichtenbergPeter von FlotowBritta HeilmeierSebastian SixtSteffen BrucksChristian ErbelUlrich BeschornerMichael WerkVicenç RiambauAndreas WienkeChristof KlumbMarkus ThiemeDierk ScheinertPublished in: Cardiovascular and interventional radiology (2022)
Primary patency after femoropopliteal DCB angioplasty remained superior to POBA throughout 5 years, however, with decreasing difference. Clinical improvement, freedom from TLR, and all-cause mortality were similar between groups over the long term. (Effectiveness of Paclitaxel-Coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Superficial Femoral Artery [EffPac]; NCT02540018).